/IRMD

IRMD Stock - IRadimed Corporation

Q: What is the analyst price target for IRMD?

Analyst price target information is not currently available for IRMD.

Q: What is IRMD's market cap?

Market capitalization information is not currently available for IRMD.

Healthcare|Medical - Devices|NASDAQ

$99.25+1.38%

+$1.35 (+1.38%) • Jan 13

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+-3.3%upside

Target: $95.97

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for IRMD

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.10

52W High$100.39

52W Low$47.48

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$73.24M	$65.56M	$53.30M	$41.81M	$31.72M
Gross Profit	$56.35M	$50.16M	$41.28M	$32.05M	$23.57M
Gross Margin	76.9%	76.5%	77.4%	76.6%	74.3%
Operating Income	$21.96M	$20.04M	$15.63M	$9.82M	$-756,091
Net Income	$19.23M	$17.19M	$12.83M	$9.33M	$1.37M
Net Margin	26.3%	26.2%	24.1%	22.3%	4.3%
EPS	$1.52	$1.36	$1.02	$0.76	$0.11

Company Overview

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.

Visit Website

Earnings History & Surprises

IRMD

Beat Rate

78%

Last 18 quarters

Avg Surprise

+13.4%

EPS vs Estimate

Beats / Misses

14/4

Last 12 quarters

Latest EPS

$0.47

Q4 2025

EPS Surprise History

Q1 24

-2.5%

$0.39vs$0.40

Q2 24

+5.9%

$0.36vs$0.34

Q3 24

+13.5%

$0.42vs$0.37

Q4 24

+10.3%

$0.43vs$0.39

Q1 25

-2.2%

$0.44vs$0.45

Q2 25

-2.3%

$0.42vs$0.43

Q3 25

+8.9%

$0.49vs$0.45

Q4 25

-2.1%

$0.47vs$0.48

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2026	May 4, 2026	—	—	—	—
Q1 2026	Feb 12, 2026	$0.49	—	—	—
Q4 2025	Nov 3, 2025	$0.48	$0.47	-2.1%	✗ MISS
Q3 2025	Aug 1, 2025	$0.45	$0.49	+8.9%	✓ BEAT
Q2 2025	May 5, 2025	$0.43	$0.42	-2.3%	✗ MISS
Q1 2025	Feb 13, 2025	$0.45	$0.44	-2.2%	✗ MISS
Q4 2024	Oct 31, 2024	$0.39	$0.43	+10.3%	✓ BEAT
Q3 2024	Aug 1, 2024	$0.37	$0.42	+13.5%	✓ BEAT
Q2 2024	May 2, 2024	$0.34	$0.36	+5.9%	✓ BEAT
Q1 2024	Feb 8, 2024	$0.40	$0.39	-2.5%	✗ MISS
Q4 2023	Nov 3, 2023	$0.36	$0.43	+19.4%	✓ BEAT
Q3 2023	Aug 3, 2023	$0.31	$0.36	+16.1%	✓ BEAT
Q2 2023	May 4, 2023	$0.28	$0.30	+7.1%	✓ BEAT
Q1 2023	Feb 2, 2023	$0.30	$0.32	+6.7%	✓ BEAT
Q4 2022	Nov 3, 2022	$0.25	$0.29	+16.0%	✓ BEAT
Q3 2022	Jul 29, 2022	$0.24	$0.26	+8.3%	✓ BEAT
Q2 2022	Apr 29, 2022	$0.21	$0.22	+4.8%	✓ BEAT
Q1 2022	Feb 4, 2022	$0.21	$0.33	+57.1%	✓ BEAT
Q4 2021	Oct 29, 2021	$0.17	$0.23	+35.3%	✓ BEAT
Q3 2021	Jul 30, 2021	$0.10	$0.14	+40.0%	✓ BEAT

Frequently Asked Questions about IRMD

What is IRMD's current stock price?

IRadimed Corporation (IRMD) is currently trading at $99.25 per share. The stock has moved +1.38% today.

What is the analyst price target for IRMD?

The average analyst price target for IRMD is $96.00, based on 1 analyst.

What sector is IRadimed Corporation in?

IRadimed Corporation operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.

What is IRMD's market cap?

IRadimed Corporation has a market capitalization of $1.26 billion, making it a small-cap company.

Does IRMD pay dividends?

No, IRadimed Corporation does not currently pay a dividend to shareholders.